Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.354,08
-0,60%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Recursion Pharmaceuticals Inc (RXRX) Recursion Pharmaceuticals Inc (RXRX) Notizie

Recursion Pharmaceuticals Inc

RXRX
8,12
0,28 (3,57%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202414:00GLOBERecursion Appoints Najat Khan, PhD, as Chief R&D Officer and..
02/4/202414:00GLOBERecursion to Participate in Upcoming Investor Conference
26/3/202413:00GLOBERecursion Publishes Annual Environmental, Social and..
11/3/202409:00GLOBERecursion Announces Plans to Open New Office in London
09/3/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:39EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:59EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:18EDGAR2Form 144 - Report of proposed sale of securities
01/3/202420:58GLOBERecursion Hosts Second Annual Rare Disease Day Events for..
01/3/202413:59GLOBERecursion to Participate in Upcoming Investor Conferences
29/2/202414:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:05GLOBERecursion Provides Business Updates and Reports Fourth..
24/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:13EDGAR2Form 144 - Report of proposed sale of securities
21/2/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:29EDGAR2Form 144 - Report of proposed sale of securities
20/2/202413:59GLOBERecursion to Host Public L(earnings) Call on February 27
17/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:50EDGAR2Form 144 - Report of proposed sale of securities
14/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:18EDGAR2Form 144 - Report of proposed sale of securities
12/2/202418:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:13EDGAR2Form 144 - Report of proposed sale of securities
07/2/202422:56EDGAR2Form 8-K - Current report
06/2/202422:12EDGAR2Form 144 - Report of proposed sale of securities
31/1/202422:40EDGAR2Form 8-K - Current report
30/1/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202422:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/1/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:23EDGAR2Form 144 - Report of proposed sale of securities
24/1/202415:00GLOBEAltitude Lab Startups Raise Over $120M in Capital
23/1/202422:20EDGAR2Form 144 - Report of proposed sale of securities
19/1/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:34EDGAR2Form 144 - Report of proposed sale of securities
16/1/202422:14EDGAR2Form 144 - Report of proposed sale of securities
16/1/202415:55EDGAR2Form 144 - Report of proposed sale of securities
12/1/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:02EDGAR2Form 144 - Report of proposed sale of securities
09/1/202422:15EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 7,86 Min: 7,68 Max: 8,1391
Chiusura: 7,84

La tua Cronologia

NASDAQ
RXRX
Recursion Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network